53.6% Below Target

The consensus Wall Street price target for HCKT is $16.5, representing 53.6% upside from the current price of $10.74. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

HCKT has a consensus rating of "Buy" based on 5 Wall Street analysts. The rating breakdown is predominantly bullish, with 5 Buy/Strong Buy ratings. The consensus 12-month price target of $16.5 implies 53.6% upside from current levels.

With a forward P/E of 7.16x, HCKT trades at a relatively low valuation. The consensus target of $16.5 implies 53.6% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $17 for HCKT, while the most conservative target is $16. The consensus of $16.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $32 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

HCKT is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 5 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month HCKT stock forecast based on 5 Wall Street analysts shows a consensus price target of $16.5, with estimates ranging from $16 (bear case) to $17 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $24, with bear/bull scenarios of $15/$32.

Our quantitative valuation model calculates HCKT's fair value at $24 (base case), with a bear case of $15 and bull case of $32. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 41/100.

HCKT trades at a forward P/E ratio of 7.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on HCKT, with a "Buy" consensus rating and $16.5 price target (53.6% upside). 5 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

HCKT analyst price targets range from $16 to $17, a 6% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $16.5 consensus represents the middle ground. Our model's $15-$32 range provides an independent fundamental perspective.